BioMediCan Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $220K

  • Investors
  • 4

BioMediCan General Information

Description

Developer of biosynthesis technology intended to develop organic, non-genetically modified organisms and rare cannabinoids using yeast fermentation to ensure the efficient production of quality compounds. The company's cannabinoids are produced using natural biological synthesis at a lower cost than conventional methods, enabling clients to conduct research and advance in synthetic biology and cellular agriculture.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 40471 Encyclopedia Circle
  • Fremont, CA 94538
  • United States
+1 (405)
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 40471 Encyclopedia Circle
  • Fremont, CA 94538
  • United States
+1 (405)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMediCan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Equity Crowdfunding 01-Oct-2021 $220K Completed Generating Revenue
3. Early Stage VC Completed Generating Revenue
2. Early Stage VC 11-Oct-2019 $2M $3M Completed Generating Revenue
1. Early Stage VC (Series AA) 29-Jan-2018 $1000K $1000K Completed Generating Revenue
To view BioMediCan’s complete valuation and funding history, request access »

BioMediCan Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series AA
To view BioMediCan’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BioMediCan Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biosynthesis technology intended to develop organic, non-genetically modified organisms and rare cannabinoi
Other Pharmaceuticals and Biotechnology
Fremont, CA
14 As of 2026

Montreal, Canada
 

Hayward, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioMediCan Competitors (6)

One of BioMediCan’s 6 competitors is Hyasynth, a Venture Capital-Backed company based in Montreal, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hyasynth Venture Capital-Backed Montreal, Canada
Demetrix Venture Capital-Backed Hayward, CA
Teewinot Life Sciences Formerly VC-backed Tampa, FL
Ginkgo Bioworks Formerly VC-backed Boston, MA
Atlas Energy (Biotechnology) Corporation Calgary, Canada
To view BioMediCan’s complete competitors history, request access »

BioMediCan Patents

BioMediCan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022051433-A1 Production of sesqui-cannabinoids Inactive 01-Sep-2020
AU-2020333745-A1 Production of cannabinoids Inactive 19-Aug-2019
CA-3148628-A1 Production of cannabinoids Pending 19-Aug-2019
EP-4017972-A1 Production of cannabinoids Inactive 19-Aug-2019
US-20220403346-A1 Production of cannabinoids Inactive 19-Aug-2019 C12N9/10
To view BioMediCan’s complete patent history, request access »

BioMediCan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioMediCan Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
HNI Corporation Minority
Steep Hill Corporation Minority
White Sheep Corporation Minority
Angel (individual) Minority
To view BioMediCan’s complete investors history, request access »

BioMediCan FAQs

  • When was BioMediCan founded?

    BioMediCan was founded in 2017.

  • Where is BioMediCan headquartered?

    BioMediCan is headquartered in Fremont, CA.

  • What is the size of BioMediCan?

    BioMediCan has 14 total employees.

  • What industry is BioMediCan in?

    BioMediCan’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is BioMediCan a private or public company?

    BioMediCan is a Private company.

  • What is BioMediCan’s current revenue?

    The current revenue for BioMediCan is .

  • How much funding has BioMediCan raised over time?

    BioMediCan has raised $4.32M.

  • Who are BioMediCan’s investors?

    HNI, Steep Hill, White Sheep, and have invested in BioMediCan.

  • Who are BioMediCan’s competitors?

    Hyasynth, Demetrix, Teewinot Life Sciences, Ginkgo Bioworks, and Atlas Energy (Biotechnology) are some of the 6 competitors of BioMediCan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process